RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
RXDX
Delisted
RXDX was delisted on the 15th of June, 2023.
41 hedge funds and large institutions have $426M invested in Prometheus Biosciences, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
41
Holders Change
+41
Holders Change %
–
% of All Funds
0.72%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.04%
New
41
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
EAM
1
Eventide Asset Management
Boston,
Massachusetts
|
$65.6M |
| 2 |
PA
2
Perceptive Advisors
New York
|
$55.4M |
| 3 |
CA
3
CHI Advisors
New York
|
$52.5M |
| 4 |
RI
4
RTW Investments
New York
|
$51.7M |
| 5 |
CAM
5
Cormorant Asset Management
Boston,
Massachusetts
|
$36.6M |
Top Sellers
No sellers this quarter
